Endothelium, Inflammation & Allogenicity
Posted by
fsena
on 30 October 2019
Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after decea- sed-donor kidney transplantation in patients with preformed donor-specific antibodies
Glotz D, Russ G, Rostaing L, Legendre C, Tufveson G, Chadban S, Grinyó J, Mamode N, Rigotti P, Couzi L, [...]
Read morePosted by
fsena
on 30 October 2019
Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial
Marks WH, Mamode N, Montgomery RA, Stegall MD, Ratner LE, Cornell LD, Rowshani AT, Colvin RB, Dain B, Boice [...]
Read morePosted by
fsena
on 30 September 2019
HLA-DQ alloantibodies directly activate the endothelium and compromise dif- ferentiation of FoxP3high regulatory T lymphocytes
Cross AR, Lion J, Poussin K, Assayag M, Taupin JL, Glotz D, Mooney N Nature: Kidney Int. 2019 Sept;96:689 Link:
Read morePosted by
fsena
on 30 September 2019
Abolishing serum interference in detection of HLA antibodies: Who, How, When and Why?
Greenshields AL, Jollet I, Liwski RS, Taupin JL, Valenzuela NM Nature: Hum Immunol. 2019 Sep;80(9):621 Link:
Read morePosted by
fsena
on 17 September 2019
Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and vali- dation study
Loupy A, Aubert O, Orandi BJ, Naesens M, Bouatou Y, Raynaud M, Divard G, Jackson AM, Viglietti D, Giral M, [...]
Read morePosted by
fsena
on 30 July 2019
Response to treatment and long-term outcomes in kidney transplant recipients with acute T cell-mediated rejection
Bouatou Y, Viglietti D, Pievani D, Louis K, Duong Van Huyen JP, Rabant M, Aubert O, Taupin JL, Glotz D, [...]
Read morePosted by
fsena
on 30 July 2019
Impact of macrolide therapy in critically ill patients with acute respiratory failure: a desirability of outcome ranking analysis to investigate the OUTCOMEREA database
Pons S, Timsit JF, Ruckly S, Schwebel C, Papazian L, Azoulay E, Reignier J, Zafrani L Nature: Intensive [...]
Read morePosted by
fsena
on 30 July 2019
Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients
Lefaucheur C, Viglietti D, Bouatou Y, Philippe A, Pievani D, Aubert O, Duong Van Huyen JP, Taupin JL, Glotz [...]
Read morePosted by
fsena
on 30 June 2019
HLA and lung transplantation
Ju L, Suberbielle C, Li X, Mooney N, Charron D Nature: Fr Med. 2019 Jun;13(3):298 Link:
Read morePosted by
fsena
on 27 May 2019
Interest and limits of assessing acute kidney injury in administrative dataset
Darmon M, Canet E, Zafrani L Nature: Ann Intensive Care. 2019 May 27;9(1):60 Link:
Read more